Search Results - Kazuyuki Numakura

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Complete remission of brain metastases in renal cell carcinoma treated with axitinib after failure with nivolumab and ipilimumab treatment by Koichiro Takayama, Kazuyuki Numakura, Ryoma Igarashi, Tomonori Habuchi

    Published in IJU Case Reports (2022-11-01)
    Get full text
    Article


  2. 2

    Incidence, Etiology, Prevention and Management of Ureteroenteric Strictures after Robot-Assisted Radical Cystectomy: A Review of Published Evidence and Personal Experience by Shintaro Narita, Mitsuru Saito, Kazuyuki Numakura, Tomonori Habuchi

    Published in Current Oncology (2021-10-01)
    Get full text
    Article


  3. 3

    Factors influencing warm ischemia time in robot-assisted partial nephrectomy change depending on the surgeon’s experience by Kazuyuki Numakura, Mizuki Kobayashi, Atsushi Koizumi, Soki Kashima, Ryohei Yamamoto, Taketoshi Nara, Mitsuru Saito, Shintaro Narita, Takamitsu Inoue, Tomonori Habuchi

    Published in World Journal of Surgical Oncology (2022-06-01)
    Get full text
    Article


  4. 4

    Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma by Kazuyuki Numakura, Ryoma Igarashi, Makoto Takahashi, Taketoshi Nara, Sohei Kanda, Mitsuru Saito, Shintaro Narita, Takamitsu Inoue, Takenori Niioka, Masatomo Miura, Tomonori Habuchi

    Published in Cancer Biology & Therapy (2024-12-01)
    Get full text
    Article


  5. 5

    Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations by Masato Kikuta, Sei Naito, Takahiro Osawa, Kazuyuki Numakura, Takafumi Narisawa, Yuki Takai, Mayu Yagi, Yuya Sekine, Ojiro Tokairin, Nobuo Shinohara, Tomonori Habuchi, Norihiko Tsuchiya

    Published in BMC Cancer (2025-01-01)
    Get full text
    Article


  6. 6

    The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox". by Ryuichi Ito, Shintaro Narita, Mingguo Huang, Taketoshi Nara, Kazuyuki Numakura, Koichiro Takayama, Hiroshi Tsuruta, Atsushi Maeno, Mitsuru Saito, Takamitsu Inoue, Norihiko Tsuchiya, Shigeru Satoh, Tomonori Habuchi

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  7. 7

    Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancer by Hiromi Sato, Shintaro Narita, Norihiko Tsuchiya, Atsushi Koizumi, Taketoshi Nara, Sohei Kanda, Kazuyuki Numakura, Hiroshi Tsuruta, Atsushi Maeno, Mitsuru Saito, Takamitsu Inoue, Shigeru Satoh, Kyoko Nomura, Tomonori Habuchi

    Published in BMC Urology (2018-05-01)
    Get full text
    Article


  8. 8

    IGFBP2 alteration contributes to prostate cancer progression by modulating prostate stroma activation by Mingguo Huang, Shintaro Narita, Hiromi Sato, Yuya Sekine, Mizuki Kobayashi, Soki Kashima, Ryohei Yamamoto, Atsushi Koizumi, Taketoshi Nara, Kazuyuki Numakura, Mitsuru Saito, Hiroshi Nanjo, Takayuki Ikezoe, Tomonori Habuchi

    Published in Cell Communication and Signaling (2025-10-01)
    Get full text
    Article


  9. 9

    The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer by Kazuyuki Numakura, Mizuki Kobayashi, Yumina Muto, Hiromi Sato, Yuya Sekine, Ryuta Sobu, Yu Aoyama, Yoshiko Takahashi, Syuhei Okada, Hajime Sasagawa, Shintaro Narita, Satoshi Kumagai, Yuki Wada, Naoko Mori, Tomonori Habuchi

    Published in Current Oncology (2023-09-01)
    Get full text
    Article


  10. 10

    Effects of Avelumab Maintenance on Advanced Urothelial Carcinoma: A Real‐World Multicenter Study by Noritaka Ishii, Yuya Sekine, Masanao Shinohara, Yohei Kawashima, Kanami Mori, Mizuki Kobayashi, Kazuyuki Numakura, Jotaro Mikami, Naoki Fujita, Teppei Okamoto, Takahiro Yoneyama, Ryuji Tabata, Satoshi Sato, Tomonori Habuchi, Chikara Ohyama, Shingo Hatakeyama

    Published in Cancer Medicine (2025-09-01)
    Get full text
    Article


  11. 11

    BRCA2 Frameshift Mutation in de novo Small-Cell Neuroendocrine Carcinoma of the Prostate: A Case Report by Keisuke Okubo, Shintaro Narita, Atsushi Koizumi, Yoshiko Takahashi, Ryuichiro Sagehashi, Kanami Mori, Ryuta Sobu, Hiromi Sato, Soki Kashima, Mizuki Kobayashi, Ryohei Yamamoto, Taketoshi Nara, Kazuyuki Numakura, Mitsuru Saito, Hiroshi Nanjyo, Tomonori Habuchi

    Published in Case Reports in Oncology (2023-08-01)
    Get full text
    Article


  12. 12

    Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma by Kazuyuki Numakura, Yuya Sekine, Shingo Hatakeyama, Yumina Muto, Ryuta Sobu, Mizuki Kobayashi, Hajime Sasagawa, Soki Kashima, Ryohei Yamamto, Taketoshi Nara, Hideo Akashi, Ryuji Tabata, Satoshi Sato, Mitsuru Saito, Shintaro Narita, Chikara Ohyama, Tomonori Habuchi

    Published in Cancer Medicine (2023-08-01)
    Get full text
    Article


  13. 13

    Clinical impact of early response to first‐line VEGFR‐TKI in patients with metastatic renal cell carcinoma on survival: A multi‐institutional retrospective study by Ryuta Sobu, Kazuyuki Numakura, Sei Naito, Shingo Hatakeyama, Renpei Kato, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Syuya Kandori, Sadafumi Kawamura, Yoichi Arai, Akihiro Ito, Hiroyuki Nishiyama, Yoshiyuki Kojima, Wataru Obara, Chikara Ohyama, Norihiko Tsuchiya, Tomonori Habuchi

    Published in Cancer Medicine (2023-02-01)
    Get full text
    Article


  14. 14

    The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological c... by Tomoyuki Koguchi, Sei Naito, Shingo Hatakeyama, Kazuyuki Numakura, Yumina Muto, Renpei Kato, Takahiro Kojima, Yoshihide Kawasaki, Kento Morozumi, Shuya Kandori, Sadafumi Kawamura, Hiroyuki Nishiyama, Akihiro Ito, Tomonori Habuchi, Wataru Obara, Chikara Ohyama, Norihiko Tsuchiya, Yoshiyuki Kojima

    Published in Cancer Medicine (2023-11-01)
    Get full text
    Article


  15. 15

    Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma by Takafumi Fukushima, Kazuyuki Numakura, Masanao Shinohara, Yohei Kawashima, Yuya Sekine, Kanami Mori, Mizuki Kobayashi, Himawari Asanuma, Takaki Ichiyama, Hisashi Sakurai, Kai Ozaki, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Satoshi Sato, Tomonori Habuchi, Chikara Ohyama, Shingo Hatakeyama

    Published in Scientific Reports (2025-07-01)
    Get full text
    Article


  16. 16

    Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study by Tomokazu Sazuka, Yuto Matsushita, Hiroaki Sato, Takahiro Osawa, Nobuyuki Hinata, Shingo Hatakeyama, Kazuyuki Numakura, Kosuke Ueda, Takahiro Kimura, Masayuki Takahashi, Hajime Tanaka, Yoshihide Kawasaki, Toshifumi Kurahashi, Takuma Kato, Kazutoshi Fujita, Makito Miyake, Takahiro Kojima, Hiroshi Kitamura, Hideaki Miyake, Tomohiko Ichikawa

    Published in Scientific Reports (2023-11-01)
    Get full text
    Article


Search Tools: